# Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release

> **NCT05398640** · — · AVAILABLE · sponsor: **Iovance Biotherapeutics, Inc.**

## Conditions studied

- Unresectable Melanoma
- Metastatic Melanoma

## Interventions

- **BIOLOGICAL:** OOS AMTAGVI

## Key facts

- **NCT ID:** NCT05398640
- **Lead sponsor:** Iovance Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05398640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05398640, "Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05398640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*